Yousaf Ali, MBBS
-
- Position
- PROFESSOR | Medicine, Rheumatology
-
- Specialty
- Rheumatology
-
- Language
- English
-
- Hospital Affiliations
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Brooklyn
- Mount Sinai Beth Israel
- Mount Sinai Queens
- The Mount Sinai Hospital
-
- Phone
- Mount Sinai Doctors Rheumatology 212-241-1671 212-241-1671
- Mount Sinai Doctors-Brooklyn Heights 212-241-1671 212-241-1671
- MOUNT SINAI DOCTORS MEDICINE MULTISPECIALTY 212-241-1671 212-241-1671
Dr. Ali is a Professor in the Mount Sinai Department of Medicine and Chief of the Division of Rheumatology at Mount Sinai West. He is a graduate of the Royal Free Hospital School of Medicine in London. After two years of postgraduate training in the UK, he moved to the US and did his Internal Medicine training at OHSU in Portland, Oregon. He completed his fellowship training in Rheumatology at Yale University and is board certified in both Rheumatology and Internal Medicine. For three years he was the Vice Chair of Faculty Affairs in the Department of Medicine.
Prior to Mount Sinai, Dr. Ali was in practice in Providence, Rhode Island for nine years, where he was an Assistant Clinical Professor of Medicine at Brown University. He is the recipient of a multitude of awards, including the prestigious Beckwith Family award for outstanding teaching. He has published numerous articles, book chapters, and has lectured widely on Rheumatoid arthritis, Osteoporosis, Gout and Osteoarthritis. His current research involves cardiovascular inflammation as it relates to Gout and he is PI on several studies including novel anticytokine targets in non-radiographic spondyloarthropathy and the role of PET imaging in patients with Rheumatoid Arthritis.
Read Dr. Ali's blog on psoriatic arthritis here.
Certification
Rheumatology
Clinical Focus
- Ankylosing Spondylitis
- Arthritis
- Arthrocentesis
- Behcet's Disease
- Dermatomyositis
- Gout
- Osteoarthritis
- Osteoporosis
- Polymyalgia Rheumatica And Giant Cell Arteritis
- Polymyositis
- Reiter's Syndrome
- Rheumatoid Arthritis
- Scleroderma
- Sjogren's Syndrome
- Systemic Lupus Erythematosus
- Temporal Arteritis
- Vasculitis
- Wegener's Granulomatosis
Education
BM, Royal Free Hospital Sch of Medicine
MD, Royal Free Hospital School of Medicine. University of London
Residency, Internal Medicine
Oregon Health Sciences University
Language
English
2021
2021 IME Excellence in Teaching Awards
Icahn School of Medicine
Master Clinician Award
2017
Stanley G. Seckler Award for Clinical and Educational Excellence in Medicine
2014
Best Doctors in NY
2007
Best Doctors in Rhode Island
Peer Award
2006
Beckwith Family Award for outstanding teaching
Brown University
2004
Teaching Recognition Award
Brown university
2001
Preceptor Award
Brown University
Top Doctors in New York
Castle Connelly
Peer Award
New topic
Dr Ali is currently PI on several trials investigating new treatments for SLE and RA. He is also developing a patient centric app to predict flares in RA that should improve care and outcome.
Embrace Study: phase 3/4, multi-center, randomized, double-blind, placebo-controlled,52-week study to evaluate the efficacy and safety of belimumab (HGS1006) in adult subjects of black race with SLE
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of CNTO 136 (sirukumab), a Human Anti-IL-6 Monoclonal Antibody, Administered Subcutaneously, in Subjects with Active Rheumatoid Arthritis Despite Anti-TNF Therapy
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Ali during 2021 and/or 2022. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting:
- Magellan rx management
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose
- Medical Education Resources (MER)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.